89 related articles for article (PubMed ID: 5855884)
21. A sensitive enzymatic assay for dopamine- -hydroxylase.
Molinoff PB; Weinshilboum R; Axelrod J
J Pharmacol Exp Ther; 1971 Sep; 178(3):425-31. PubMed ID: 5571894
[No Abstract] [Full Text] [Related]
22. On the mechanism of oxidative cleavage of aryl-alkyl ethers by liver microsomes.
Renson J; Weissbach H; Udenfriend S
Mol Pharmacol; 1965 Sep; 1(2):145-8. PubMed ID: 5835695
[No Abstract] [Full Text] [Related]
23. [On the question of a "reserpine-like" effect of prenylamine (Segontin)].
Grobecker H; Palm D; Bak IJ; Schmid B
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):215-6. PubMed ID: 5804244
[No Abstract] [Full Text] [Related]
24. The effect of diphenylhydantoin in vitro on the metabolism of testosterone by rat liver slices.
Sholiton LJ; Werk EE; MacGee J
Acta Endocrinol (Copenh); 1967 Nov; 56(3):490-8. PubMed ID: 6072467
[No Abstract] [Full Text] [Related]
25. Effect of pretreatment of rabbits with phenobarbital or 3-methylcholanthrene on the distribution of drug-metabolizing enzyme activity in subfractions of hepatic microsomes.
Gram TE; Rogers LA; Fouts JR
J Pharmacol Exp Ther; 1967 Aug; 157(2):435-45. PubMed ID: 6039834
[No Abstract] [Full Text] [Related]
26. [Tyrosine metabolism in insects. XVIII. Activity of phenylalanine-4-hydroxylase and the N-acetyldopamine glucoside-forming system in vivo during the development of Calliphora erythrocephala Meigen].
Schlörer J; Sekeris CE; Karlson P
Hoppe Seylers Z Physiol Chem; 1970 Aug; 351(8):1035-40. PubMed ID: 5451275
[No Abstract] [Full Text] [Related]
27. Phenylalanine hydroxylase activity in mammalian cells.
Tourian A; Goddard J; Puck TT
J Cell Physiol; 1969 Apr; 73(2):159-70. PubMed ID: 5789918
[No Abstract] [Full Text] [Related]
28. Inhibition of dopamine beta-hydroxylase by aromatic and alkyl thioureas.
Johnson GA; Boukma SJ; Kim EG
J Pharmacol Exp Ther; 1969 Aug; 168(2):229-34. PubMed ID: 5803305
[No Abstract] [Full Text] [Related]
29. ENZYMATIC FORMATION OF O-METHYLATED DIHYDROXY DERIVATIVES FROM PHENOLIC AMINES AND INDOLES.
AXELROD J; INSCOE JK; DALY J
J Pharmacol Exp Ther; 1965 Jul; 149():16-22. PubMed ID: 14334285
[No Abstract] [Full Text] [Related]
30. Tissue fractionation and catecholamines. I. Latency and activation properties of dopamine-beta-hydroxylase in adrenal medulla.
Belpaire F; Laduron P
Biochem Pharmacol; 1968 Mar; 17(3):411-21. PubMed ID: 5661653
[No Abstract] [Full Text] [Related]
31. Regional and subcellular distribution of tyrosine hydroxylase.
Fahn S; Cote L
Neurology; 1968 Mar; 18(3):293-4. PubMed ID: 5690382
[No Abstract] [Full Text] [Related]
32. Biosynthesis of gibberellins. 3. The conversion of (-)-kaurene to (-)-kauren-19-oic acid in endosperm of Echinocystis macrocarpa Greene.
Dennis DT; West CA
J Biol Chem; 1967 Jul; 242(14):3293-300. PubMed ID: 4382094
[No Abstract] [Full Text] [Related]
33. Serum dopamine-beta-hydroxylase activity.
Weinshilboum R; Axelrod J
Circ Res; 1971 Mar; 28(3):307-15. PubMed ID: 4925832
[No Abstract] [Full Text] [Related]
34. Elevation of serum dopamine-beta-hydroxylase activity with forced immobilization.
Weinshilboum RM; Kvetnansky R; Axelrod J; Kopin IJ
Nat New Biol; 1971 Apr; 230(17):287-8. PubMed ID: 4930611
[No Abstract] [Full Text] [Related]
35. The metabolism of tyramine-H3 in different regions of the CNS.
Anagnoste B; Goldstein M
Life Sci; 1967 Jul; 6(14):1535-40. PubMed ID: 4382651
[No Abstract] [Full Text] [Related]
36. Detoxication of tyramine by the flavin-containing monooxygenase: stereoselective formation of the trans oxime.
Lin J; Cashman JR
Chem Res Toxicol; 1997 Aug; 10(8):842-52. PubMed ID: 9282832
[TBL] [Abstract][Full Text] [Related]
37. Tyramine metabolism and migraine: a metabolic defect.
Mullen PE; Smith I
Br J Pharmacol; 1971 Feb; 41(2):413P-414P. PubMed ID: 5572308
[No Abstract] [Full Text] [Related]
38. [Specificity of thyroidal and hepatic microsomal iodotyrosine deiodinase].
Dumas P; Maziere B; Autissier N; Michel R
Biochim Biophys Acta; 1973 Jan; 293(1):36-47. PubMed ID: 4685283
[No Abstract] [Full Text] [Related]
39. The in vivo production of a potent, long-acting hypotensive metabolite from diallylmelamine.
Zins GR
J Pharmacol Exp Ther; 1965 Oct; 150(1):109-17. PubMed ID: 5853691
[No Abstract] [Full Text] [Related]
40. Alteration in tyramine metabolism by ethanol.
Tacker M; Creaven PJ; McIsaac WM
Biochem Pharmacol; 1970 Feb; 19(2):604-7. PubMed ID: 5507668
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
